Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hyo-Jung | - |
dc.contributor.author | Song, Kwon-Ho | - |
dc.contributor.author | Oh, Se Jin | - |
dc.contributor.author | Kim, Suyeon | - |
dc.contributor.author | Cho, Eunho | - |
dc.contributor.author | Kim, Jungwon | - |
dc.contributor.author | Park, Yun Gyu | - |
dc.contributor.author | Lee, Kyung-Mi | - |
dc.contributor.author | Yee, Cassian | - |
dc.contributor.author | Song, Seung-Hwa | - |
dc.contributor.author | Chang, Suhwan | - |
dc.contributor.author | Choi, Jungmin | - |
dc.contributor.author | Jung, Sang Taek | - |
dc.contributor.author | Kim, Tae Woo | - |
dc.date.accessioned | 2022-06-09T23:40:18Z | - |
dc.date.available | 2022-06-09T23:40:18Z | - |
dc.date.created | 2022-06-09 | - |
dc.date.issued | 2022-04-19 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/141785 | - |
dc.description.abstract | Immunotherapy has emerged as a powerful approach to cancer treatment. However, immunotherapeutic resistance limits its clinical application. Therefore, identifying immune-resistant factors, which can be targeted by clinically available drugs and it also can be a companion diagnostic marker, is needed to develop combination strategies. Here, using the transcriptome data of patients, and immune-refractory tumor models, we identify TCTP as an immune-resistance factor that correlates with clinical outcome of anti-PD-L1 therapy and confers immune-refractory phenotypes, decreased T cell trafficking to the tumor and resistance to cytotoxic T lymphocyte-mediated tumor cell killing. Mechanistically, TCTP activates the EGFR-AKT-MCL-1/CXCL10 pathway by phosphorylation-dependent interaction with Na, K ATPase. Furthermore, treatment with dihydroartenimsinin, the most effective agent impending the TCTP-mediated-refractoriness, synergizes with T cell-mediated therapy to control immune-refractory tumors. Thus, our findings suggest a role of TCTP in promoting immune-refractoriness, thereby encouraging a rationale for combination therapies to enhance the efficacy of T cell-mediated therapy. Translationally controlled tumor protein (TCTP) regulates several cellular processes, including apoptosis, and is overexpressed in several cancer types. Here, the authors report that high levels of TCTP are associated with poor response to anti-PD-L1 and that TCTP targeting increases the efficacy of T cell-mediated anti-tumor therapy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PORTFOLIO | - |
dc.title | Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Yun Gyu | - |
dc.contributor.affiliatedAuthor | Kim, Tae Woo | - |
dc.identifier.doi | 10.1038/s41467-022-29611-y | - |
dc.identifier.scopusid | 2-s2.0-85128409990 | - |
dc.identifier.wosid | 000784997300062 | - |
dc.identifier.bibliographicCitation | NATURE COMMUNICATIONS, v.13, no.1 | - |
dc.relation.isPartOf | NATURE COMMUNICATIONS | - |
dc.citation.title | NATURE COMMUNICATIONS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | PROTEIN TCTP | - |
dc.subject.keywordPlus | CANCER-IMMUNITY | - |
dc.subject.keywordPlus | HUMAN PROSTATE | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | DIHYDROARTEMISININ | - |
dc.subject.keywordPlus | IMMUNOTHERAPY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | BLOCKADE | - |
dc.subject.keywordPlus | ESCAPE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.